COVIP study: Corona Virus disease (COVID19) in Very Elderly Intensive care Patients (VIPs)

A multinational, multicenter study of outcomes and prognostic factors in coronavirus disease (COVID-19) in very old intensive care patients.

Click to register your ICU now

You will receive further information when you register.
See the COVIP page for information, country coordinator list, protocol, documents, notes and ethical approval etc.

274 ICUs
(Updated: 18-09-2020 21:14)
38 countries
(Updated: 18-09-2020 21:14)
1633 patients
(Updated: 18-09-2020 21:14)

See the
COVIP study
information page

The COVIP study is endorsed by ESICM (European Intensive Care Society)

VIP1 and VIP2 studies

The VIP1 and VIP2 studes were international, multicenter studies of the old intensive care unit population. There are among the largest prospective studies conducted in the elderly intensive care population. The data from VIP2 is currently being analyzed and published.